SPAC: Translational Development Acquisition Corp. (TDAC)

Company

SPAC: Translational Development Acquisition Corp. (TDAC)

StatusDec 23, 2024
SPACSPAC
Unit SplitUnit Split

Industry: BLANK CHECKS

With Free you can see target company details from the merger vote, as a guest after the merger, and with Pro earlier.
  1. 0%SPAC/IPOIPODec 2024Unit Split · Feb 2025
    0%SPAC/IPOIPODec 2024Unit Split · Feb 2025
  2. 25%LOILOI
    25%LOILOI
  3. 50%AgreementDeal
    50%AgreementDeal
  4. 75%Merger voteVote
    75%Merger voteVote
  5. 100%MergerMerger
    100%MergerMerger

SPAC/IPO · Dec 2024 · Unit Split · Feb 2025

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business, industry, sector, or geographical location, and intends to focus on industries that complement its management team’s background, and intends to capitalize on the ability of its management team to identify and acquire a business.

The Company’s management team is led by Michael B. Hoffman, its Chief Executive Officer and Chairman of the Board of Directors of the Company (the “Board”) and Avanindra C. Das, Chief Financial Officer. In addition, the Board includes E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum and Christopher Jarratt.

BTIG, LLC is acting as sole book-running manager for the offering.

Chart/Sentiment

Financials

Translational Development Acquisition Corp. (TDAC)

Latest quarterly filing: 10-Q
Period endTrust Assets
2026-06-30157.3 m USD
2025-12-31181.7 m USD
2024-12-31174.4 m USD
2023-12-310 USD

Source: SEC Company Facts · USD. Some values may be calculated; please verify them against the official SEC filings.

Scroll to Top